[HTML][HTML] Malaria transmission-blocking vaccines—how can their development be supported?
R Carter, KN Mendis, LH Miller, L Molineaux, A Saul - Nature medicine, 2000 - nature.com
R Carter, KN Mendis, LH Miller, L Molineaux, A Saul
Nature medicine, 2000•nature.comCOMMENTARY transmission-blocking effects of vaccination against malaria, the scientific
community and its funders have made much progress towards the technical development of
this type of malaria vaccine9, TBV development has proceeded slowly, mainly because of
the lack of a committed industrial partner. It is timely, therefore, to ask how essential TBVs
would really be for malaria control, and, if they were developed, how this could be achieved.
A meeting* to discuss these issues included representatives from the pharmaceutical …
community and its funders have made much progress towards the technical development of
this type of malaria vaccine9, TBV development has proceeded slowly, mainly because of
the lack of a committed industrial partner. It is timely, therefore, to ask how essential TBVs
would really be for malaria control, and, if they were developed, how this could be achieved.
A meeting* to discuss these issues included representatives from the pharmaceutical …
COMMENTARY transmission-blocking effects of vaccination against malaria, the scientific community and its funders have made much progress towards the technical development of this type of malaria vaccine9, TBV development has proceeded slowly, mainly because of the lack of a committed industrial partner. It is timely, therefore, to ask how essential TBVs would really be for malaria control, and, if they were developed, how this could be achieved.
A meeting* to discuss these issues included representatives from the pharmaceutical industry and major funding agencies, scientific experts with detailed knowledge and experience in the technical aspects of malaria vaccine development and regional representatives and experts in malaria epidemiology and in medical ethics. This meeting’s purpose was to achieve an authoritative statement on the issues concerning malaria TBVs (ref. 10).
nature.com